0001104659-23-057260.txt : 20230508 0001104659-23-057260.hdr.sgml : 20230508 20230508171719 ACCESSION NUMBER: 0001104659-23-057260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230505 FILED AS OF DATE: 20230508 DATE AS OF CHANGE: 20230508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gruia Gabriela CENTRAL INDEX KEY: 0001860326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 23898929 MAIL ADDRESS: STREET 1: C/O TSCAN THERAPEUTICS, INC. STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 267-370-5219 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 4 1 tm2314936-2_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-05-05 0 0001781983 Aprea Therapeutics, Inc. APRE 0001860326 Gruia Gabriela 3805 OLD EASTON ROAD DOYLESTOWN, PA 18902 1 0 0 0 0 Stock Options (Right to Buy) 3.8999 2023-05-05 4 A 0 12500 0.00 A 2033-05-05 Common Stock 12500 12500 D These options shall vest in full on May 5, 2024, subject to the reporting person's continued service through and including the applicable vesting date. /s/ John Hamill, Attorney-in-fact 2023-05-08